Phosphatidylinositol‐3′‐kinase/AKT signaling is essential in synovial sarcoma
Nicolaus Friedrichs(University Hospital Cologne), Wolfgang Hartmann(University Hospital Münster)
Cited by 52
Related Papers
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
|PLoS ONE|2015|228
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
|Nature Medicine|2016|185
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
|Nature Communications|2019|72
<scp>SRC</scp> inhibition represents a potential therapeutic strategy in liposarcoma
|International Journal of Cancer|2015|24
SS18-SSX drives CREB activation in synovial sarcoma
|Cellular Oncology|2022|9